|Videos|November 22, 2022
PharmExec Interviews Christophe Bourdon at Pharma 2022
Advertisement
In this video, Christophe Bourdon, CEO, LEO Pharma highlights his keynote presentation to the Pharma 2022 audience, where he describes his recent leadership at LEO Pharma and how he is moving to deploying and redeploying resources in an agile way, as well as what patient centricity from a dermatology standpoint means.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Lilly’s Orforglipron, Retatrutide Named as Defining GLP-1 Drugs of the Next Decade
2
Eli Lilly Enters $1.2 Billion Definitive Agreement to Acquire Ventyx Biosciences
3
FDA Limits Regulations on Non-Medical Grade Wearable Fitness Devices
4
GSK Enters Multi-Year Collaboration with Helix to Develop Precision Medications
5